Ebola Vaccine Development Race Between the USA and China

The Ebola Hemorrhagic Fever (EHF) outbreak in West Africa during 2013–2016 was the first to impact both rural and urban areas, reported the Centers for Disease Control and Prevention (CDC).

The West Africa Ebola virus evolved from a localized problem to an extensive pandemic, with 28,000 people infected and 11,000 fatalities.

The Ebola virus is very contagious and is spread through inhalation, ingestion and or passage through breaks in the skin when an uninfected person comes in contact with blood or other body fluids, says the CDC.

During March, 2018, a review of the Ebola recovery projects in Guinea, Liberia, and Sierra Leone by the US Government Accountability Office (GAO) found that, of $1.6 billion appropriated by Congress in 2014 for US Agency for International Development (USAID), that the USAID needs to do more to prepare for future Ebola recovery projects.

And one of these projects is developing an Ebola vaccine.

And, it appears the US military is racing China to bring an Ebola vaccine to market.

Read the entire article here to see who is winning the vaccine race.